Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Merighi

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
British Journal of Pharmacology|September 29, 2011
Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharideStefania Merighi, Stefania Gessi, Katia Varani, et al.
Frontiers in Pharmacology|December 28, 2020
A<sub>1</sub> Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?Fabrizio Vincenzi, Silvia Pasquini, Enrica Battistello, et al.
Cells|May 24, 2020
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric ModulationFabrizio Vincenzi, Silvia Pasquini, Stefania Gessi, et al.
International Journal of Molecular Sciences|February 15, 2022
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic TargetsSilvia Pasquini, Chiara Contri, Stefania Merighi, et al.
Medicinal Research Reviews|December 16, 2016
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor AntagonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
Expert Opinion on Therapeutic Targets|June 14, 2019
Targeting A3 and A2A adenosine receptors in the fight against cancerStefania Merighi, Enrica Battistello, Luca Giacomelli, et al.
Current Topics in Medicinal Chemistry|February 3, 2004
Receptor binding thermodynamics at the neuronal nicotinic receptorPier Andrea Borea, Katia Varani, Stefania Gessi, et al.
Glia|May 19, 2015
A<sub>2a</sub> and a<sub>2b</sub> adenosine receptors affect HIF-1α signaling in activated primary microglial cellsStefania Merighi, Pier Andrea Borea, Angela Stefanelli, et al.
The Journal of Biological Chemistry|March 19, 2005
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Biochemical Pharmacology|May 10, 2006
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
British Journal of Pharmacology|September 29, 2011
Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharideStefania Merighi, Stefania Gessi, Katia Varani, et al.
Frontiers in Pharmacology|December 28, 2020
A<sub>1</sub> Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?Fabrizio Vincenzi, Silvia Pasquini, Enrica Battistello, et al.
Cells|May 24, 2020
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric ModulationFabrizio Vincenzi, Silvia Pasquini, Stefania Gessi, et al.
International Journal of Molecular Sciences|February 15, 2022
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic TargetsSilvia Pasquini, Chiara Contri, Stefania Merighi, et al.
Medicinal Research Reviews|December 16, 2016
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor AntagonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
Expert Opinion on Therapeutic Targets|June 14, 2019
Targeting A3 and A2A adenosine receptors in the fight against cancerStefania Merighi, Enrica Battistello, Luca Giacomelli, et al.
Current Topics in Medicinal Chemistry|February 3, 2004
Receptor binding thermodynamics at the neuronal nicotinic receptorPier Andrea Borea, Katia Varani, Stefania Gessi, et al.
Glia|May 19, 2015
A<sub>2a</sub> and a<sub>2b</sub> adenosine receptors affect HIF-1α signaling in activated primary microglial cellsStefania Merighi, Pier Andrea Borea, Angela Stefanelli, et al.
The Journal of Biological Chemistry|March 19, 2005
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Biochemical Pharmacology|May 10, 2006
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Pageof 11